Description
I. The Arterial Wall in the Pathogenesis of Atherosclerosis.- II. Lipoproteins and Proteins of the Arterial Wall.- III. Lipids of the Arterial Wall.- IV. Enzymes of the Arterial Wall.- V. Metabolic Functions of the Arterial Cell.- VI. Permeability of the Arterial Wall and Connective Tissue Reactions.- VII. Platelets-Thrombogenesis-Fibrinogen-Fibrinolysis.- VIII. Animal Models of Atherosclerosis.- IX. Liproprotein and Lipid Metabolism in Experimental Animals.- X. Hyperlipoproteinemia and Lipoprotein Disorders - Genetics and Epidemiology.- XI. Plasma Lipids.- XII. Lipolytic Enzymes.- XIII. Factors Contributing to Genesis of Hyperlipoproteinemia and/or Atherosclerosis.- XIV. Plasma Lipoproteins.- XV. Risk Factors.- XVI. Prevention.- XVII. Dietary Management of Hyperlipoproteinemias.- XVIII. Drug Therapy of Hyperlipoproteinemia.- XIX. Surgical Treatment of Arteriosclerosis.- Abstracts.- References.
Contents
I. The Arterial Wall in the Pathogenesis of Atherosclerosis.- II. Lipoproteins and Proteins of the Arterial Wall.- III. Lipids of the Arterial Wall.- IV. Enzymes of the Arterial Wall.- V. Metabolic Functions of the Arterial Cell.- VI. Permeability of the Arterial Wall and Connective Tissue Reactions.- VII. Platelets-Thrombogenesis-Fibrinogen-Fibrinolysis.- VIII. Animal Models of Atherosclerosis.- IX. Liproprotein and Lipid Metabolism in Experimental Animals.- X. Hyperlipoproteinemia and Lipoprotein Disorders — Genetics and Epidemiology.- XI. Plasma Lipids.- XII. Lipolytic Enzymes.- XIII. Factors Contributing to Genesis of Hyperlipoproteinemia and/or Atherosclerosis.- XIV. Plasma Lipoproteins.- XV. Risk Factors.- XVI. Prevention.- XVII. Dietary Management of Hyperlipoproteinemias.- XVIII. Drug Therapy of Hyperlipoproteinemia.- XIX. Surgical Treatment of Arteriosclerosis.- Abstracts.- References.
